Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Tschumperlin"'
Publikováno v:
Journal of Clinical and Translational Science, Vol 6, Pp 58-58 (2022)
OBJECTIVES/GOALS: Idiopathic Pulmonary Fibrosis (IPF) is a fatal disease of lung scarring. Aberrant vascular remodeling is a contributor to IPF progression. We have identified CCN3 as an endothelial gene that is upregulated in resolving but not in pe
Externí odkaz:
https://doaj.org/article/bfc692ad4a384683a89dcad73b9b4b4f
Autor:
Naimish R Patel, Medhavi Bole, Cheng Chen, Charles C Hardin, Alvin T Kho, Justin Mih, Linhong Deng, James Butler, Daniel Tschumperlin, Jeffrey J Fredberg, Ramaswamy Krishnan, Henry Koziel
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e41024 (2012)
Macrophages serve to maintain organ homeostasis in response to challenges from injury, inflammation, malignancy, particulate exposure, or infection. Until now, receptor ligation has been understood as being the central mechanism that regulates macrop
Externí odkaz:
https://doaj.org/article/dcc7691e0a0b4faf9febcdc0ef9abf40
Autor:
Faping Wang, Shaohua Wang, Chujie Zhang, Xue Tian, Yongfang Zhou, Weixia Xuan, Eric L. Matteson, Fengming Luo, Daniel Tschumperlin, Robert Vassallo
Publikováno v:
American journal of physiology. Lung cellular and molecular physiology.
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited survival. Janus kinases (JAKs), tyrosine kinases that transduce cytokine-mediated signals, are known to be involved, but their specific roles in lung fibrosis are not well
Autor:
Ashley Gao, Ana M Diaz Espinosa, Ba Bao N Nguyen, Patrick A Link, Jeffrey Meridew, Dakota L Jones, Daniel F Gibbard, Daniel Tschumperlin, Andrew J Haak
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. :JPET-AR
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.